Taken together, our data suggests that UMP supplementation restores ceramide metabolism and improves obesity through a molecular pathway involving an HIF2α‐ACER2 signaling axis. The gene discussed is EPAS1; the disease is obesity due to melanocortin 4 receptor deficiency.